Yumanity Therapeutics
Founded
2014
2014
Geography
United States of America based
United States of America based
Funding
$82.100 M
$82.100 M
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Technologies
Pharmaceutical and Drug DiscoveryR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet